Editorial on the Research TopicEmerging mosquito-borne diseases and novel biocontrol strategies Mosquito-borne diseases threaten more than 40% of the world's population and are an increasingly serious global health challenge (Franklinos et al., 2019). A report released by the World Health Organization (WHO) showed that malaria caused 247 million cases and 619,000 deaths in 2021, and there is no significant progress in current malaria control (World Health Organization, 2023a). The global incidence and number of reported epidemic areas of dengue have also grown dramatically (World Health Organization, 2023). Moreover, Zika, a newly emerged mosquito-borne disease associated with neurological complications, has recently caused several large outbreaks involving 89 countries and territories (World Health Organization, 2023b). Furthermore, no efficient vaccines or drugs for diseases such as dengue and Zika are publicly available, and vector control remains largely dependent on traditional insecticide-based strategies (Namias et al., 2021).Notably, the limitation of the current vector control effect is partly due to the overreliance on chemical control (Fernandes et al., 2018). Chemical insecticides used to be the primary strategy for mosquito control, but insecticide resistance has widely emerged in mosquitoes in recent years (World Health Organization, 2018;. Extensive use of insecticides both in mosquito control and agriculture led to environmental pollution and exerted effects on non-targeted organisms . Thus, there is a growing need for more sustainable, environmentally friendly, and low-cost vector control strategies that can be implemented on a large scale to harness insecticide-resistant mosquitoes and reduce mosquito-borne disease burden.Biological control agents are important alternatives or complements to chemical insecticides. Combined with genetic approaches (e.g., transgenesis and paratransgenesis) and other biological rear and release theories, novel approaches, including entomopathogenic fungi (Metarhizium anisopliae and Beauveria bassiana) , symbiotic bacteria (Wolbachia) (Turelli et al., 2022), lethal bacteria (Bacillus thuringiensis)Frontiers in Cellular and Infection Microbiology frontiersin.org 01